Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Treatment.com International ( (TSE:TRUE) ) has provided an announcement.
Treatment.com AI Inc. has announced its acquisition of Rocket Doctor Inc. as part of its strategy to enhance healthcare delivery through AI. The CEOs of both companies discussed the potential of their combined technologies to address inefficiencies in the healthcare sector, aiming to improve patient care and support healthcare providers. This acquisition is expected to strengthen Treatment.com’s market position by integrating Rocket Doctor’s digital health platform with its AI capabilities, potentially impacting stakeholders by offering more comprehensive healthcare solutions.
More about Treatment.com International
Treatment.com AI Inc. operates in the healthcare industry, focusing on utilizing artificial intelligence and clinical practices to improve healthcare services. The company has developed the Global Library of Medicine (GLM), a comprehensive AI engine that supports healthcare professionals by providing expert medical reviews, recommended tests, and administrative support to enhance patient care. Rocket Doctor Inc. is a digital health platform that offers tools for virtual and hybrid healthcare models, aiming to increase access to affordable and quality healthcare.
YTD Price Performance: 6.36%
Average Trading Volume: 7,602
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $20.3M
For detailed information about TRUE stock, go to TipRanks’ Stock Analysis page.
